ARVN peer analysis
Arvinas (ARVN) against its competitors: price, today's move, 1-year return and market value side by side.
ARVN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CCCC C4 Therapeutics | $2.59 | -2.26% | 4.86% | $340.11M |
| FHTX Foghorn Therapeutics | $1.83 | 2.23% | -60.98% | $109.73M |
| GLUE Monte Rosa Therapeutics | $9.07 | -0.98% | -36.84% | $775.03M |
| KYMR Kymera Therapeutics | $121.52 | -3.44% | 87.13% | $10.37B |
| NRIX Nurix Therapeutics | $14.90 | 1.15% | 16.41% | $1.63B |
| ARVN Arvinas | $6.82 | 0.74% | -35.48% | $446.61M |
- ARVN's peers: CCCC (C4 Therapeutics), FHTX (Foghorn Therapeutics), GLUE (Monte Rosa Therapeutics), KYMR (Kymera Therapeutics), NRIX (Nurix Therapeutics).
Updated 2026-11-18 05:48 UTC